Minimed Group, Inc. MMED
NASDAQ
| 07/31/2026 | 04/24/2026 | 01/23/2026 | 10/24/2025 | 07/25/2025 | |
|---|---|---|---|---|---|
| Revenue | 15.13% | 13.72% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.13% | 13.72% | -- | -- | -- |
| Cost of Revenue | 20.99% | 19.50% | -- | -- | -- |
| Gross Profit | 10.56% | 9.23% | -- | -- | -- |
| SG&A Expenses | 10.27% | 9.12% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 462.22% | 307.14% | -- | -- | -- |
| Total Operating Expenses | 16.98% | 15.45% | -- | -- | -- |
| Operating Income | -107.23% | -127.27% | -- | -- | -- |
| Income Before Tax | -25.68% | -40.00% | -- | -- | -- |
| Income Tax Expenses | 125.23% | 129.81% | -- | -- | -- |
| Earnings from Continuing Operations | -52.11% | -63.71% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 20.00% | 6.25% | -- | -- | -- |
| Net Income | -47.11% | -58.45% | -- | -- | -- |
| EBIT | -107.23% | -127.27% | -- | -- | -- |
| EBITDA | -18.21% | -16.48% | -- | -- | -- |
| EPS Basic | -218.27% | -166.13% | -- | -- | -- |
| Normalized Basic EPS | -182.24% | -193.76% | -- | -- | -- |
| EPS Diluted | -218.82% | -166.44% | -- | -- | -- |
| Normalized Diluted EPS | -182.24% | -193.76% | -- | -- | -- |
| Average Basic Shares Outstanding | 5.74% | 53.04% | -- | -- | -- |
| Average Diluted Shares Outstanding | 39.07% | 103.03% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |